August 2026
Largest Contract Research & Manufacturing Public Companies in Taiwan
Benchmark revenue and EBITDA valuation multiples for public comps like
Bora Pharmaceuticals, Scinopharm Taiwan, Savior Lifetec, Mycenax Biotech and BRIM Biotechnology.
 | Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Commercial sales segment, Contract Development & Manufacturing Organization segment, and Other segment. The majority of revenue is derived from the Commercial sales segment. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions. | $13 | -45% | $1.7B | $2.1B | 3.5x | 9.7x | ||
| Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. The company also conducts consulting and technical services. The Company's sales revenue mainly arises from the manufacture and sales of Active Pharmaceutical Ingredient and injection products. | $1 | +1% | $463M | $388M | 4.0x | 18.6x | ||
| Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions: the Americas, Asia, Taiwan, and Europe. | $1 | -1% | $189M | $144M | 3.9x | 7.3x | ||
| Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards. The company’s main operating region is located in Taiwan. | $1 | -38% | $157M | $187M | 8.1x | (44.1x) | ||
| BRIM Biotechnology Inc applies integrated and efficient translational science to develop new treatments that help combat and cure disease. Its lead product candidate, BRM421, is on track to treat Dry Eye Syndrome (DES) which treats and repairs corneal damage. Its product help to treat Neurotrophic Keratitis, osteoarthritis, and corneal damage repair. | $1 | -- | $87M | $54M | 316.8x | (4.3x) | ||
| Median | $1 | -19% | $189M | $187M | 4.0x | 7.3x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.